Nantes University Hospital

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1503-01-01

Employees: 10K

Market Cap: -

Website: https://www.chu-nantes.fr

Clinical Trials

Effect of Low Level Laser Therapy on Pain Occurring After Insertion of an Orthodontic Device

Not Applicable

Completed

Conditions: Bad Molar Teeth Arrangement Requiring Orthodontic Device

Interventions: Procedure: sham procedure
Device: Low level laser therapy

First Posted Date: 2012-12-10

Last Posted Date: 2013-02-05

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 69

Registration Number: NCT01745653

Locations: 🇫🇷
Nantes Universitary Hospital, Nantes, Loire Atlantique, France

Pharmacological Study of High Doses of Ceftriaxone in Meningitidis

Phase 4

Completed

Conditions: Meningitis
Neurological Infections

Interventions: Drug: Ceftriaxone treatment

First Posted Date: 2012-12-10

Last Posted Date: 2016-10-05

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 198

Registration Number: NCT01745679

Locations: 🇫🇷
Angers Universitary Hospital, Angers, France
🇫🇷
Nantes Universitary Hospital, Nantes, Loire Atlantique, France
🇫🇷
La Roche/Yon hospital, La Roche/Yon, France

and more 4 locations

Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients

Not Applicable

Conditions: Long QT Syndrome Type 1 or 2

Interventions: Other: exercise test
Other: Epinephrine test

First Posted Date: 2012-12-10

Last Posted Date: 2016-10-05

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 130

Registration Number: NCT01745666

Locations: 🇫🇷
Marseille Universitary Hospital, Marseille, France
🇫🇷
Bordeaux Universitary Hospital, Bordeaux, France
🇫🇷
Nantes Universitary Hospital, Nantes, France

and more 5 locations

Screening and Understanding of the Pre-diabetes: DECODIAB

Not Applicable

Conditions: Pre-diabetes

First Posted Date: 2012-12-04

Last Posted Date: 2015-04-16

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 103

Registration Number: NCT01739868

Locations: 🇫🇷
Nantes University Hospital, Nantes, France

Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)

Phase 2

Terminated

Conditions: Systemic Lupus

Interventions: Drug: Arsenic trioxide

First Posted Date: 2012-11-30

Last Posted Date: 2016-01-06

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 11

Registration Number: NCT01738360

Locations: 🇫🇷
CHU de Marseille, Marseille, France
🇫🇷
Nantes University Hospital, Nantes, France
🇫🇷
CHRU de Strasbourg, Strasbourg, France

and more 3 locations

Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells

Not Applicable

Terminated

Conditions: Inherited Arrhythmias and Valvulopathies

Interventions: Other: Skin biopsies

First Posted Date: 2012-11-27

Last Posted Date: 2014-11-07

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 20

Registration Number: NCT01734356

Locations: 🇫🇷
Nantes University Hospital, Nantes, France

Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles

Phase 4

Completed

Conditions: Parkinson's Disease
Secondary Behavioural Addiction

Interventions: Other: questionnaires

First Posted Date: 2012-11-26

Last Posted Date: 2018-02-15

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 225

Registration Number: NCT01733199

Locations: 🇫🇷
Nantes University Hospital, Nantes, France

ImmunoTEP for Patients With Medullary Thyroid Carcinoma.

Phase 1

Completed

Conditions: Medullary Thyroid Carcinoma

Interventions: Drug: • TF2 and 68 Ga-IMP-288

First Posted Date: 2012-11-21

Last Posted Date: 2022-07-26

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 25

Registration Number: NCT01730638

Locations: 🇫🇷
Nantes Hospital, Nantes, France
🇫🇷
Angers Hospital, Angers, France
🇫🇷
Institut de Cancérologie de l'ouest, René Gauducheau, Saint-Herblain, France

ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA

Phase 1

Completed

Conditions: HER2 Negative Breast Carcinoma Expressing CEA

First Posted Date: 2012-11-21

Last Posted Date: 2018-07-27

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 23

Registration Number: NCT01730612

Locations: 🇫🇷
Hospital, Nantes, France
🇫🇷
Institut de Cancérologie de l'Ouest, Saint Herblain, France

Clinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired Pneumonia

Not Applicable

Completed

Conditions: Community-acquired Pneumonia

Interventions: Other: the clinical reassessment arm
Other: the procalcitonin arm

First Posted Date: 2012-11-08

Last Posted Date: 2017-05-31

Lead Sponsor: Nantes University Hospital

Target Recruit Count: 286

Registration Number: NCT01723644

Locations: 🇫🇷
University hospital of Agen, Agen, France
🇫🇷
University Hospital of Grenoble, Grenoble, France
🇫🇷
University Hospital of Rennes, Rennes, France

and more 12 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy